Barry Funkhouser, Paul Biderman and guests discuss living with ultra-rare diseases. The goal of this podcasts is to raise awareness about rare illness and the people who live with them. You can even listen to it right on the new website or on Spotify. In the most recent episode, Investigating adding ABL and related disorders…
Read MoreABL+ Foundation at the Harvard 2024 Rare Disease Hackathon
At the Harvard 2024 Rare Disease Hackathon this past March, Paul Biderman and Dr. Cindy Bredefeld represented the ABL+ Foundation and met with Caltech undergraduate Yoyo Benchetrit, who is studying biology and chemistry. This event introduced Yoyo to abetalipoproteinemia (ABL) for the first time. After speaking with Dr. Bredefeld, Yoyo shared: “I was able to…
Read MoreDr. Hussain working for the ABL+ community
1 – International registry and biorepository. Abetalipoproteinemia and related disorders are poorly understood ultra-rare diseases that are frequently met with suboptimal treatment. The Abetalipoproteinemia & Related Disorders Foundation recognized that an international registry to identify patients for clinical studies and a biorepository to identify biomarkers associated with disease progression would facilitate new treatment modalities. In this regard, Dr. Mahmood Hussain from…
Read MoreThe Nord Summit 2024
The Nord Summit 2024 (https://nordsummit.org/) took place on October 22-24 in Washington DC, joining over 900 patient leaders, researchers and scientists, healthcare advocates, pharma and biotech innovators, government agencies, and others to tackle the most pressing issues facing the rare disease community. National Organization for Rare Diseases (https://rarediseases.org/) is a mission-driven nonprofit improving the health…
Read MoreThe ABL+ Foundation new home on the internet: www.ablplusfoundation.org
The old ablfoundation.org website is gone, but the domain now redirects to our new website, focused heavily on all of the hypolipidemia illnesses the ABL+ Foundation considers interrelated. Comprehensive information on Abetalipoproteinemia, Familial Hypobetalipoproteinemia, and Chylomicron Retention Disease is available on our website. This site is designed to be helpful and informative for patients and…
Read More